Social Determinants of Health HCC Trial

Conditions

• HCC - Hepatocellular Carcinoma

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Social Determinants of Health Program — OTHER
  Social resources to be offered under our SDOH program will include 1) rideshares to treatment-related visits, 2) hotel stays for treatment-related visits, and/or 3) a 12-week meal delivery program.
• Patient Navigation — OTHER
  Usual clinic-provided patient navigation to appointments, scheduling, social resources, financial challenges, etc.

Study Details

The goal of this study is to test whether providing various social resources (transportation support through Lyft rides, housing support through Hyatt House LA, and meal support through Project Angel Food LA) will reduce treatment delays and increase treatment uptake for patients with liver cancer.

Key Dates

Start date

Jun 30, 2026

Status verified

Apr 2026

Primary completion

Jun 30, 2028

Completion

Sep 30, 2028

Study Design

Enrollment

75 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Arms

• Experimental: SDOH and patient navigation program
  Transportation support through Lyft rideshares, housing support through Hyatt House LA - University Medical Center, and meal support through Project Angel Food LA
• Active Comparator: Patient navigation only
  For the duration of the intervention, patients will have access to patient navigation as per usual care. The intensity and frequency of navigation is dependent on the treating clinic; the provider of navigation (whether nurse vs social worker) is also variable by clinic. This includes: coordination of care including assistance with scheduling follow-up visits, labs, imaging, and procedures, help with filling out forms for insurance, FMLA or disability benefits, facilitating communication with treating providers, referral to community and patient support groups, providing patients with educational materials and resources, check-ins on well-being and any cancer- or treatment-related concerns

Primary Outcome Measure

Proportion of participants with treatment uptake within 90 days [ Time Frame: 90 days ]

Central Contacts

• Kali Zhou
  323-452-2293
  [email protected]

Locations (3)

Find similar trials in Los Angeles, CA

Related Studies

• Defining the Ablative Dose for Y-90 TARE
  PHASE2 · Not Yet Recruiting · Northwestern University · Chicago, Illinois